An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT02782845 · COMPLETED

Trial details

NCT number: NCT02782845
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 2006-06-01
Primary completion: 2007-10-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.